Frequently Asked Question (FAQ) Accounting for Subsequent Expenditure on Biological Assets in terms of IFRS for SMEs
Summary
The purpose of this FAQ is to highlight the accounting treatment for subsequent
expenditure on biological assets, measured at fair value less costs to sell within the
scope of Section 34 – Specialised Activities of the International Financial Reporting
Standard for Small and Medium-sized Entities (IFRS for SMEs)
| Author | SAICA Accounting Practices Committee |
|---|---|
| Division | CPR - Financial reporting |
| Keywords | SAICA FAQ Financial Reporting Subsequent expenditure Biological assets |
| Categories | Financial Reporting |
| Date | March 2021 |
| File |